Strong Revenue Growth:
ARR milestones—surpassing $100M in 2024 and $200M in January 2026—point to rapid scaling over roughly two years. Additional signals like repeated inclusion on fast‑growth lists and observed headcount expansion reinforce an expanding topline and organizational footprint.
Investor Backing & Capital Strength:
A $100M Series E in April 2024 at about a $1.6B valuation provided resources to invest in product and go‑to‑market. Stated plans to fund enterprise and international expansion, alongside current scale above $200M ARR, underscore capital‑supported execution.
Market Expansion:
Enterprise traction and international growth are emphasized, including stronger EMEA momentum, new offices in London and Sydney, and the largest customer to date in Germany’s healthcare sector. A strategic alliance with EY in 2026 further extends reach into large finance transformation programs.
